Annual EBITDA:
$12.81M+$129.14M(+111.01%)Summary
- As of today, BCRX annual EBITDA is $12.81 million, with the most recent change of +$129.14 million (+111.01%) on December 31, 2024.
- During the last 3 years, BCRX annual EBITDA has risen by +$134.55 million (+110.52%).
- BCRX annual EBITDA is now at all-time high.
Performance
BCRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$28.07M+$3.48M(+14.18%)Summary
- As of today, BCRX quarterly EBITDA is $28.07 million, with the most recent change of +$3.48 million (+14.18%) on June 30, 2025.
- Over the past year, BCRX quarterly EBITDA has increased by +$15.52 million (+123.63%).
- BCRX quarterly EBITDA is now at all-time high.
Performance
BCRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$63.11M+$15.52M(+32.60%)Summary
- As of today, BCRX TTM EBITDA is $63.11 million, with the most recent change of +$15.52 million (+32.60%) on June 30, 2025.
- Over the past year, BCRX TTM EBITDA has increased by +$106.97 million (+243.89%).
- BCRX TTM EBITDA is now at all-time high.
Performance
BCRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
BCRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +111.0% | +123.6% | +243.9% |
| 3Y3 Years | +110.5% | +183.4% | +150.7% |
| 5Y5 Years | +113.3% | +179.1% | +156.4% |
BCRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +108.9% | at high | +162.0% | at high | +143.9% |
| 5Y | 5-Year | at high | +107.6% | at high | +151.3% | at high | +134.3% |
| All-Time | All-Time | at high | +107.6% | at high | +151.3% | at high | +134.3% |
BCRX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $28.07M(+14.2%) | $63.11M(+32.6%) |
| Mar 2025 | - | $24.58M(+2093.8%) | $47.59M(+271.6%) |
| Dec 2024 | $12.81M(+111.0%) | -$1.23M(-110.5%) | $12.81M(+153.1%) |
| Sep 2024 | - | $11.69M(-6.8%) | -$24.11M(+45.0%) |
| Jun 2024 | - | $12.55M(+223.0%) | -$43.86M(+56.9%) |
| Mar 2024 | - | -$10.20M(+73.3%) | -$101.68M(+12.6%) |
| Dec 2023 | -$116.33M(+19.1%) | -$38.16M(-373.8%) | -$116.33M(+5.3%) |
| Sep 2023 | - | -$8.05M(+82.2%) | -$122.79M(+6.0%) |
| Jun 2023 | - | -$45.26M(-82.1%) | -$130.57M(-9.8%) |
| Mar 2023 | - | -$24.86M(+44.3%) | -$118.95M(+17.3%) |
| Dec 2022 | -$143.85M(-18.2%) | -$44.61M(-181.7%) | -$143.85M(-50.1%) |
| Sep 2022 | - | -$15.83M(+52.9%) | -$95.82M(+23.0%) |
| Jun 2022 | - | -$33.65M(+32.4%) | -$124.44M(-3.4%) |
| Mar 2022 | - | -$49.76M(-1552.9%) | -$120.30M(+1.2%) |
| Dec 2021 | -$121.74M(+27.3%) | $3.42M(+107.7%) | -$121.74M(+32.3%) |
| Sep 2021 | - | -$44.46M(-50.7%) | -$179.87M(-1.0%) |
| Jun 2021 | - | -$29.50M(+42.4%) | -$178.12M(+3.3%) |
| Mar 2021 | - | -$51.20M(+6.4%) | -$184.12M(-10.1%) |
| Dec 2020 | -$167.56M(-74.0%) | -$54.70M(-28.1%) | -$167.25M(-49.5%) |
| Sep 2020 | - | -$42.71M(-20.3%) | -$111.90M(-8.1%) |
| Jun 2020 | - | -$35.51M(-3.4%) | -$103.56M(-1.1%) |
| Mar 2020 | - | -$34.33M(-5382.2%) | -$102.46M(-6.4%) |
| Dec 2019 | -$96.28M(-5.4%) | $650.00K(+101.9%) | -$96.28M(+20.9%) |
| Sep 2019 | - | -$34.37M(+0.1%) | -$121.75M(-6.4%) |
| Jun 2019 | - | -$34.41M(-22.2%) | -$114.44M(-19.1%) |
| Mar 2019 | - | -$28.15M(-13.4%) | -$96.09M(-5.2%) |
| Dec 2018 | -$91.31M(-61.6%) | -$24.82M(+8.3%) | -$91.31M(-9.2%) |
| Sep 2018 | - | -$27.06M(-68.5%) | -$83.62M(-20.5%) |
| Jun 2018 | - | -$16.06M(+31.3%) | -$69.38M(-2.1%) |
| Mar 2018 | - | -$23.37M(-36.4%) | -$67.94M(-20.2%) |
| Dec 2017 | -$56.51M(-17.3%) | -$17.13M(-33.7%) | -$56.51M(-35.9%) |
| Sep 2017 | - | -$12.82M(+12.3%) | -$41.58M(-7.6%) |
| Jun 2017 | - | -$14.62M(-22.4%) | -$38.66M(+0.4%) |
| Mar 2017 | - | -$11.95M(-443.0%) | -$38.81M(+19.4%) |
| Dec 2016 | -$48.17M(-28.0%) | -$2.20M(+77.8%) | -$48.17M(+23.2%) |
| Sep 2016 | - | -$9.89M(+33.1%) | -$62.73M(+5.2%) |
| Jun 2016 | - | -$14.77M(+30.7%) | -$66.18M(-46.6%) |
| Mar 2016 | - | -$21.32M(-27.2%) | -$45.15M(-20.0%) |
| Dec 2015 | -$37.64M(+5.9%) | -$16.75M(-25.6%) | -$37.64M(-20.6%) |
| Sep 2015 | - | -$13.34M(-313.2%) | -$31.20M(-23.1%) |
| Jun 2015 | - | $6.26M(+145.3%) | -$25.34M(+43.7%) |
| Mar 2015 | - | -$13.80M(-33.8%) | -$44.98M(-12.4%) |
| Dec 2014 | -$40.01M(-59.9%) | -$10.32M(-38.1%) | -$40.01M(-18.3%) |
| Sep 2014 | - | -$7.47M(+44.1%) | -$33.83M(-2.2%) |
| Jun 2014 | - | -$13.38M(-51.3%) | -$33.10M(-8.0%) |
| Mar 2014 | - | -$8.84M(-114.1%) | -$30.64M(-22.4%) |
| Dec 2013 | -$25.03M(+25.9%) | -$4.13M(+38.8%) | -$25.03M(+18.2%) |
| Sep 2013 | - | -$6.75M(+38.2%) | -$30.60M(+5.1%) |
| Jun 2013 | - | -$10.92M(-238.2%) | -$32.25M(+0.1%) |
| Mar 2013 | - | -$3.23M(+66.7%) | -$32.29M(+4.4%) |
| Dec 2012 | -$33.79M(+35.4%) | -$9.71M(-15.6%) | -$33.79M(+12.1%) |
| Sep 2012 | - | -$8.40M(+23.4%) | -$38.45M(+9.9%) |
| Jun 2012 | - | -$10.96M(-132.0%) | -$42.68M(+6.7%) |
| Mar 2012 | - | -$4.72M(+67.1%) | -$45.74M(+12.5%) |
| Dec 2011 | -$52.29M(-65.5%) | -$14.37M(-13.9%) | -$52.29M(-12.3%) |
| Sep 2011 | - | -$12.62M(+10.0%) | -$46.55M(-4.3%) |
| Jun 2011 | - | -$14.02M(-24.4%) | -$44.61M(-10.1%) |
| Mar 2011 | - | -$11.27M(-30.6%) | -$40.52M(-28.3%) |
| Dec 2010 | -$31.59M(-160.5%) | -$8.63M(+19.2%) | -$31.59M(-322.8%) |
| Sep 2010 | - | -$10.68M(-7.6%) | -$7.47M(-5.3%) |
| Jun 2010 | - | -$9.93M(-324.8%) | -$7.09M(-29.3%) |
| Mar 2010 | - | -$2.34M(-115.1%) | -$5.49M(+54.8%) |
| Dec 2009 | -$12.12M | $15.48M(+250.3%) | -$12.12M(+30.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2009 | - | -$10.30M(-23.7%) | -$17.34M(-7.0%) |
| Jun 2009 | - | -$8.33M(+7.3%) | -$16.20M(+22.4%) |
| Mar 2009 | - | -$8.98M(-187.4%) | -$20.87M(+18.3%) |
| Dec 2008 | -$25.54M(+17.4%) | $10.27M(+212.0%) | -$25.54M(+33.9%) |
| Sep 2008 | - | -$9.17M(+29.5%) | -$38.62M(+5.9%) |
| Jun 2008 | - | -$13.00M(+4.7%) | -$41.04M(-16.0%) |
| Mar 2008 | - | -$13.64M(-385.5%) | -$35.38M(-57.6%) |
| Dec 2007 | -$30.91M(+33.1%) | -$2.81M(+75.7%) | -$22.44M(+25.6%) |
| Sep 2007 | - | -$11.59M(-57.9%) | -$30.15M(+13.5%) |
| Jun 2007 | - | -$7.34M(-933.8%) | -$34.86M(+9.0%) |
| Mar 2007 | - | -$709.80K(+93.3%) | -$38.32M(+17.0%) |
| Dec 2006 | -$46.17M(-75.5%) | -$10.52M(+35.4%) | -$46.17M(-7.5%) |
| Sep 2006 | - | -$16.29M(-50.9%) | -$42.93M(-25.0%) |
| Jun 2006 | - | -$10.80M(-26.1%) | -$34.35M(-17.4%) |
| Mar 2006 | - | -$8.56M(-17.6%) | -$29.27M(-11.2%) |
| Dec 2005 | -$26.31M(-26.5%) | -$7.28M(+5.6%) | -$26.31M(-8.6%) |
| Sep 2005 | - | -$7.71M(-34.9%) | -$24.23M(-11.5%) |
| Jun 2005 | - | -$5.71M(-1.9%) | -$21.73M(-3.5%) |
| Mar 2005 | - | -$5.61M(-7.9%) | -$21.00M(-1.0%) |
| Dec 2004 | -$20.79M(-65.3%) | -$5.20M(+0.3%) | -$20.79M(-6.2%) |
| Sep 2004 | - | -$5.21M(-4.5%) | -$19.58M(-11.7%) |
| Jun 2004 | - | -$4.99M(+7.6%) | -$17.52M(-13.1%) |
| Mar 2004 | - | -$5.40M(-35.6%) | -$15.49M(-23.2%) |
| Dec 2003 | -$12.58M(+27.9%) | -$3.98M(-26.2%) | -$12.58M(+4.5%) |
| Sep 2003 | - | -$3.15M(-6.6%) | -$13.17M(-0.4%) |
| Jun 2003 | - | -$2.96M(-19.1%) | -$13.12M(+12.9%) |
| Mar 2003 | - | -$2.48M(+45.7%) | -$15.07M(+15.9%) |
| Dec 2002 | -$17.46M(-343.5%) | -$4.58M(-47.4%) | -$17.92M(-14.5%) |
| Sep 2002 | - | -$3.10M(+36.7%) | -$15.64M(-26.2%) |
| Jun 2002 | - | -$4.91M(+8.0%) | -$12.39M(-72.5%) |
| Mar 2002 | - | -$5.33M(-131.2%) | -$7.18M(-71.6%) |
| Dec 2001 | -$3.94M(+57.0%) | -$2.31M(-1678.8%) | -$4.19M(+12.3%) |
| Sep 2001 | - | $146.00K(-52.1%) | -$4.77M(+29.0%) |
| Jun 2001 | - | $305.00K(+113.1%) | -$6.72M(+27.7%) |
| Mar 2001 | - | -$2.33M(+19.4%) | -$9.29M(-0.8%) |
| Dec 2000 | -$9.16M(-20.6%) | -$2.89M(-60.8%) | -$9.22M(-6.9%) |
| Sep 2000 | - | -$1.80M(+20.5%) | -$8.62M(+7.5%) |
| Jun 2000 | - | -$2.27M(-0.4%) | -$9.32M(-26.6%) |
| Mar 2000 | - | -$2.26M(+1.9%) | -$7.36M(+1.9%) |
| Dec 1999 | -$7.60M(-38.2%) | -$2.30M(+8.0%) | -$7.51M(-8.7%) |
| Sep 1999 | - | -$2.50M(-711.4%) | -$6.91M(-262.0%) |
| Jun 1999 | - | -$308.00K(+87.2%) | -$1.91M(+57.6%) |
| Mar 1999 | - | -$2.40M(-41.2%) | -$4.50M(+13.5%) |
| Dec 1998 | -$5.50M(+53.0%) | -$1.70M(-168.0%) | -$5.20M(+23.5%) |
| Sep 1998 | - | $2.50M(+186.2%) | -$6.80M(+42.9%) |
| Jun 1998 | - | -$2.90M(+6.5%) | -$11.90M(-5.3%) |
| Mar 1998 | - | -$3.10M(+6.1%) | -$11.30M(+2.6%) |
| Dec 1997 | -$11.70M(-42.7%) | -$3.30M(-26.9%) | -$11.60M(-1.8%) |
| Sep 1997 | - | -$2.60M(-13.0%) | -$11.40M(-2.7%) |
| Jun 1997 | - | -$2.30M(+32.4%) | -$11.10M(-12.1%) |
| Mar 1997 | - | -$3.40M(-9.7%) | -$9.90M(-19.3%) |
| Dec 1996 | -$8.20M(+3.5%) | -$3.10M(-34.8%) | -$8.30M(-13.7%) |
| Sep 1996 | - | -$2.30M(-109.1%) | -$7.30M(-4.3%) |
| Jun 1996 | - | -$1.10M(+38.9%) | -$7.00M(+6.7%) |
| Mar 1996 | - | -$1.80M(+14.3%) | -$7.50M(+10.7%) |
| Dec 1995 | -$8.50M(-37.1%) | -$2.10M(-5.0%) | -$8.40M(-3.7%) |
| Sep 1995 | - | -$2.00M(-25.0%) | -$8.10M(-6.6%) |
| Jun 1995 | - | -$1.60M(+40.7%) | -$7.60M(+1.3%) |
| Mar 1995 | - | -$2.70M(-50.0%) | -$7.70M(-22.2%) |
| Dec 1994 | -$6.20M | -$1.80M(-20.0%) | -$6.30M(-40.0%) |
| Sep 1994 | - | -$1.50M(+11.8%) | -$4.50M(-50.0%) |
| Jun 1994 | - | -$1.70M(-30.8%) | -$3.00M(-130.8%) |
| Mar 1994 | - | -$1.30M | -$1.30M |
FAQ
- What is BioCryst Pharmaceuticals, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. annual EBITDA year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
- What is BioCryst Pharmaceuticals, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for BioCryst Pharmaceuticals, Inc.?
- What is BioCryst Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
What is BioCryst Pharmaceuticals, Inc. annual EBITDA?
The current annual EBITDA of BCRX is $12.81M
What is the all-time high annual EBITDA for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high annual EBITDA is $12.81M
What is BioCryst Pharmaceuticals, Inc. annual EBITDA year-on-year change?
Over the past year, BCRX annual EBITDA has changed by +$129.14M (+111.01%)
What is BioCryst Pharmaceuticals, Inc. quarterly EBITDA?
The current quarterly EBITDA of BCRX is $28.07M
What is the all-time high quarterly EBITDA for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high quarterly EBITDA is $28.07M
What is BioCryst Pharmaceuticals, Inc. quarterly EBITDA year-on-year change?
Over the past year, BCRX quarterly EBITDA has changed by +$15.52M (+123.63%)
What is BioCryst Pharmaceuticals, Inc. TTM EBITDA?
The current TTM EBITDA of BCRX is $63.11M
What is the all-time high TTM EBITDA for BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. all-time high TTM EBITDA is $63.11M
What is BioCryst Pharmaceuticals, Inc. TTM EBITDA year-on-year change?
Over the past year, BCRX TTM EBITDA has changed by +$106.97M (+243.89%)